← Open Payments lookup

SYDNEY CAMPBELL: Open Payments

NPI 1053182972 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 71 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,026 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$183
ABBVIE INC.9$158
Noven Therapeutics, LLC9$149
Takeda Pharmaceuticals U.S.A., Inc.10$143
Axsome Therapeutics, Inc.6$128
Neurocrine BioSciences, Inc.4$97
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$87
Tris Pharma Inc3$70
Vanda Pharmaceuticals Inc.3$69
Teva Pharmaceuticals USA, Inc.3$62

Products named: REXULTI, VRAYLAR, Xelstrym, TRINTELLIX, Auvelity, INGREZZA, CAPLYTA, Dyanavel XR.

Industry payments across FL — which companies pay providers there.